Skip to main content
. 2012 Jun;50(6):1874–1878. doi: 10.1128/JCM.00106-12

Fig 1.

Fig 1

(A) Plasma VL at study entry (day 0) and 2 to 10 days later in acutely infected persons detected by both NAT and HIV Combo assay; (B) plasma VL over time for the five acutely infected persons missed by the HIV Combo assay (day 0 is the day of HIV detection by NAT).